Controlled Drugs in NHS Community Services: Safe Storage, Administration and Audit in Home-Based Care
Controlled drugs are increasingly managed within NHS medicines management and delegated healthcare across NHS community service models and pathways, particularly in people’s homes. While this supports person-centred care and avoids unnecessary admission, it introduces risks around storage, administration, diversion and documentation. Safe systems must balance accessibility for symptom control with strong audit and governance controls.
Why Controlled Drugs Carry Distinct Risk in Community Settings
Unlike ward environments, community teams operate across dispersed locations, often without immediate peer oversight. Stock may be held in patients’ homes, in mobile clinical bags or within community bases. Governance therefore depends on clarity of accountability, routine audit and escalation processes.
Operational Example 1: End-of-Life Pathway at Home
Context: A community palliative care team identified variation in controlled drug documentation across home visits.
Support approach: A standardised controlled drug administration record (CDAR) template was introduced for home-based care, including mandatory dual-signature where possible and explicit reconciliation at each visit.
Day-to-day delivery detail: Nurses verified stock against recorded balance before and after administration. Any discrepancy triggered immediate senior clinical review and documentation in incident systems.
Evidence of effectiveness: Audit over two quarters demonstrated 100% reconciliation compliance and no unresolved discrepancies, with improved inspector confidence during CQC review.
Operational Example 2: Community Base Stock Governance
Context: A district nursing service held small volumes of controlled drugs at base for urgent use.
Support approach: A weekly stock check regime was introduced, led by a named controlled drugs accountable lead.
Day-to-day delivery detail: Electronic stock logs were cross-checked with physical counts. Variances required same-day investigation and documented learning review.
Evidence of effectiveness: Documentation accuracy improved from 88% to 99% within two audit cycles, with reduced time spent resolving discrepancies.
Operational Example 3: Delegated Administration in Supported Living
Context: In a supported living service, delegated administration of controlled analgesia raised concerns around storage access.
Support approach: A locked storage protocol was implemented with named key holders and daily balance checks recorded in care notes and medicines logs.
Day-to-day delivery detail: Supervisory spot checks were conducted monthly by registered clinicians, with documented review of competency and documentation standards.
Evidence of effectiveness: No safeguarding alerts related to diversion or mismanagement were recorded following protocol implementation.
Commissioner Expectation
Commissioner expectation: Commissioners expect providers to demonstrate robust controlled drug policies aligned with national guidance, supported by routine audit data and clear accountability structures.
Regulator Expectation (CQC)
Regulator expectation: CQC inspectors routinely review controlled drug records, storage arrangements and reconciliation practices. They expect staff to articulate escalation processes and demonstrate oversight beyond written policy.
Safeguarding and Diversion Risk
Controlled drugs present safeguarding risks not only to the person receiving care but also to staff and the wider community. Governance frameworks must therefore include incident reporting, whistleblowing routes and proactive monitoring of unusual administration patterns.
Governance Structures That Withstand Scrutiny
- Named accountable lead for controlled drugs
- Routine reconciliation at each administration
- Threshold-based incident escalation
- Quarterly thematic review of discrepancies
When controlled drug governance is explicit, routinely audited and clinically led, home-based care can remain both compassionate and safe. Without such systems, risk accumulates invisibly until exposed through incident or inspection.